title: Case-control study of neuroleptic malignant syndrome.
abstract: OBJECTIVE
  The authors performed a case-control study of neuroleptic malignant syndrome to identify potential risk factors.
  
  
  METHODS
  Twenty-five patients with neuroleptic malignant syndrome were matched with 50 comparison subjects on age, sex, primary psychiatric diagnosis, and time of admission to the hospital. The records of all subjects were reviewed independently by two researchers for information on postulated risk factors. Exploratory direct comparisons of the two groups were followed by a conditional logistic regression analysis.
  
  
  RESULTS
  Patients with neuroleptic malignant syndrome were more likely to be agitated or dehydrated before the development of neuroleptic malignant syndrome, often needed restraint or seclusion, and received larger doses of neuroleptics soon after hospitalization. Previous treatment with ECT increased vulnerability.
  
  
  CONCLUSIONS
  The prevalence of neuroleptic malignant syndrome may be reduced by avoiding large doses of neuroleptics over short periods in the management of acute psychosis and by paying adequate attention to the patient's hydration and electrolyte status.
authors.affiliation: School of Psychiatry, University of New South Wales, Australia. P.Sachdev@unsw.edu.au
authors.forename: P
authors.initials: P
authors.lastname: Sachdev
authors.forename: C
authors.initials: C
authors.lastname: Mason
authors.forename: D
authors.initials: D
authors.lastname: Hadzi-Pavlovic
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects; D016022:Case-Control Studies; D004565:Electroconvulsive Therapy / Q000009:adverse effects; D005260:Female; D006753:Hospital Records / Q000706:statistics & numerical data; D006760:Hospitalization; D006801:Humans; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000453:epidemiology*; D009517:New South Wales / Q000453:epidemiology; D011618:Psychotic Disorders / Q000188:drug therapy / Q000628:therapy; D012044:Regression Analysis; D012307:Risk Factors
chemical_list: D014150:Antipsychotic Agents